Who
Peter J. Mariani
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Cytosorbents; EVP & Chief Financial Officer, Axogen; Chief Financial Officer, Hansen Medical; Controller and CAO, Guidant.
In numbers
- Trades disclosed
- 132
- Buys
- 5
- Sells
- 14
- Bought
- $160K
- Sold
- $2.4M
- Companies
- 4
- Companies where not an officer
- 0
- First trade
- 31 Mar 2006
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $44K100,000 at $0.44 | filing |
| 15 Jun 2026filed 16 Jun 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $44K100,000 at $0.44 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —71,500 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code O | $37K32,625 at $1.13 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code O | $37K32,625 at $1.13 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code X | —32,625 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —32,625 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —32,625 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code X | $33K32,625 at $1.00 | filing |
| 13 Dec 2024filed 16 Dec 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $19K20,000 at $0.96 | filing |
| 12 Dec 2024filed 13 Dec 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $18K20,000 at $0.89 | filing |
| 11 Dec 2024filed 13 Dec 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $10K11,363 at $0.89 | filing |
| 14 Aug 2024filed 16 Aug 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —215,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 11 Dec 2023filed 13 Dec 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $11K1,410 at $7.52 | filing |
| 11 Dec 2023filed 13 Dec 2023 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $23K3,120 at $7.51 | filing |
News
Critical Survey: Cytosorbents (NASDAQ:CTSO) & Trinity Biotech (NASDAQ:TRIB)CTSO · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Peter J. Mariani; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.